content top

Problems of Anti-VEGF Therapy in Massive Subretinal Hemorrhage in Wet AMD

Actuality: In most cases, the period and the gradual reduction of visual acuity in AMD allows patients to adapt to low vision without a sudden loss of central vision and independence. In case of a massive subretinal hemorrhage on the basis of AMD, patients experience sudden loss of central vision and the associated debasement in the quality of life. A-VEGF therapy in the treatment of subretinal hemorrhage, appears ambiguous. Changes in...

Read More

Algorithm of Surgical Treatment & Rehabilitation of Patients with Tractional RD and ME in Diabetes Type I

Actuality: Proliferative diabetic retinopathy (PDR) is one of the most common complications of diabetes type I. Proliferative retinal changes lead to a sharp vision reduction and, consequently, loss of life quality in young able-bodied patients. Modern technology of vitreoretinal surgery can be successfully used to eliminate the effects of the proliferative process in an eye and improve vision up to its full recovery. However, in most...

Read More

Morphology of PED as a Predicting Factor of Outcomes for Anti-VEGF Therapy of Wet AMD

SCIENTIFIC POSTER_Elena Kozina OCT-criteria for a potential risk of pigment epithelium (PE) tear development, PE reattaching and PED resistance at A-VEGF therapy of patients with wet AMD, accompanied by high PE detachment are determined retrosprctively for predicting the possible treatment outcome and determination of the optimal mode of A-VEGF injection. General Considerations: In clinical practice the different morphological forms of...

Read More
content top